Bionano Genomics (BNGO) Stock Price

Bionano Genomics Price

NASDAQ·CLOSED
1.16USD+0.00 (+0.00 %)
Market closed

Over the last 9 years Bionano Genomics grew revenue by 19.1% annually, reaching 28.21 M USD. For Bionano Genomics, the net margin of -93.6% is up versus -424.7% a few years ago. The consensus 12-month price target for Bionano Genomics is 7.65 USD, about 559.5% above where the stock trades today. Of 9 analysts, 7 rate the stock a buy — an overall Buy consensus. Bionano Genomics's share price has lost 41.4% over the last twelve months. The stock trades about 9% above its 52-week low.

Bionano Genomics stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Bionano Genomics over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bionano Genomics stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bionano Genomics's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Bionano Genomics Stock Price History
DateBionano Genomics Price
8/10/20261.16 USD
8/7/20261.16 USD
8/6/20261.10 USD
8/5/20261.07 USD
8/4/20261.12 USD
8/3/20261.12 USD
7/31/20261.07 USD
7/30/20261.06 USD
7/29/20261.08 USD
7/27/20261.09 USD
7/23/20261.11 USD
7/22/20261.12 USD
7/21/20261.12 USD
7/20/20261.13 USD
7/17/20261.15 USD
7/16/20261.17 USD
7/15/20261.19 USD
7/14/20261.15 USD
7/13/20261.17 USD
7/10/20261.20 USD
7/9/20261.14 USD
7/8/20261.14 USD
7/7/20261.14 USD
7/6/20261.15 USD
7/2/20261.15 USD
7/1/20261.17 USD
6/30/20261.13 USD
6/29/20261.17 USD
6/26/20261.14 USD
6/25/20261.12 USD
6/24/20261.13 USD
6/23/20261.15 USD
6/22/20261.15 USD
6/18/20261.14 USD
6/17/20261.16 USD
6/16/20261.15 USD
6/15/20261.16 USD
6/12/20261.16 USD
6/11/20261.19 USD
6/10/20261.16 USD
6/9/20261.16 USD
6/8/20261.17 USD
6/5/20261.17 USD
6/4/20261.26 USD
6/3/20261.30 USD
6/2/20261.26 USD
6/1/20261.25 USD
5/29/20261.24 USD
5/28/20261.25 USD
5/27/20261.23 USD
5/26/20261.22 USD
5/22/20261.24 USD
5/21/20261.23 USD
5/20/20261.24 USD
5/19/20261.17 USD
5/18/20261.16 USD
5/15/20261.15 USD
5/14/20261.19 USD
5/13/20261.25 USD
5/12/20261.26 USD
5/11/20261.27 USD
5/8/20261.29 USD
5/7/20261.33 USD
5/6/20261.27 USD
5/5/20261.24 USD
5/4/20261.24 USD
5/1/20261.18 USD
4/30/20261.16 USD
4/29/20261.16 USD
4/28/20261.19 USD
4/27/20261.23 USD
4/24/20261.21 USD
4/23/20261.21 USD
4/22/20261.25 USD
4/21/20261.26 USD
4/20/20261.31 USD
4/17/20261.29 USD
4/16/20261.26 USD
4/15/20261.28 USD
4/14/20261.21 USD
4/13/20261.18 USD
4/10/20261.13 USD
4/9/20261.16 USD
4/8/20261.18 USD
4/7/20261.17 USD
4/6/20261.15 USD
4/2/20261.20 USD
4/1/20261.19 USD
3/31/20261.17 USD
3/30/20261.13 USD
3/27/20261.16 USD
3/26/20261.15 USD
3/25/20261.20 USD
3/24/20261.18 USD
3/23/20261.46 USD
3/20/20261.15 USD
3/19/20261.12 USD
3/18/20261.12 USD
3/17/20261.13 USD
3/16/20261.11 USD
3/13/20261.11 USD
3/12/20261.12 USD
3/11/20261.15 USD
3/10/20261.13 USD
3/9/20261.12 USD
3/6/20261.12 USD
3/5/20261.13 USD
3/4/20261.15 USD
3/3/20261.12 USD
3/2/20261.14 USD
2/27/20261.15 USD
2/26/20261.15 USD
2/25/20261.15 USD
2/24/20261.12 USD
2/23/20261.13 USD
2/20/20261.14 USD
2/19/20261.16 USD
2/18/20261.14 USD
2/17/20261.10 USD
2/13/20261.10 USD
2/12/20261.09 USD
2/11/20261.14 USD
2/10/20261.17 USD
2/9/20261.15 USD
2/6/20261.15 USD
2/5/20261.13 USD
2/4/20261.19 USD
2/3/20261.20 USD
2/2/20261.27 USD
1/30/20261.30 USD
1/29/20261.47 USD
1/28/20261.51 USD
1/27/20261.54 USD
1/26/20261.53 USD
1/23/20261.62 USD
1/22/20261.67 USD
1/21/20261.58 USD
1/20/20261.44 USD
1/16/20261.50 USD
1/15/20261.52 USD
1/14/20261.55 USD
1/13/20261.58 USD
1/12/20261.59 USD
1/9/20261.58 USD
1/8/20261.60 USD
1/7/20261.60 USD
1/6/20261.61 USD
1/5/20261.59 USD
1/2/20261.59 USD
12/31/20251.53 USD
12/30/20251.50 USD
12/29/20251.49 USD
12/26/20251.52 USD
12/24/20251.52 USD
12/23/20251.53 USD
12/22/20251.57 USD
12/19/20251.60 USD
12/18/20251.59 USD
12/17/20251.52 USD
12/16/20251.57 USD
12/15/20251.54 USD
12/12/20251.62 USD
12/11/20251.66 USD
12/10/20251.68 USD
12/9/20251.66 USD
12/8/20251.64 USD
12/5/20251.68 USD
12/4/20251.70 USD
12/3/20251.73 USD
12/2/20251.68 USD
12/1/20251.72 USD
11/28/20251.85 USD
11/26/20251.81 USD
11/25/20251.74 USD
11/24/20251.68 USD
11/21/20251.62 USD
11/20/20251.49 USD
11/19/20251.54 USD
11/18/20251.55 USD
11/17/20251.50 USD
11/14/20251.52 USD
11/13/20251.47 USD
11/12/20251.60 USD
11/11/20251.62 USD
11/10/20251.62 USD
11/7/20251.63 USD
11/6/20251.61 USD
11/5/20251.69 USD
11/4/20251.70 USD
11/3/20251.72 USD
10/31/20251.80 USD
10/30/20251.79 USD
10/29/20251.82 USD
10/28/20251.87 USD
10/27/20251.91 USD
10/24/20251.93 USD
10/23/20251.91 USD
10/22/20251.92 USD
10/21/20251.90 USD
10/20/20251.98 USD
10/17/20251.90 USD
10/16/20251.99 USD
10/15/20252.12 USD
10/14/20252.09 USD
10/13/20251.96 USD
10/10/20251.95 USD
10/9/20252.13 USD
10/8/20251.98 USD
10/7/20252.01 USD
10/6/20252.04 USD
10/3/20251.92 USD
10/2/20251.89 USD
10/1/20251.74 USD
9/30/20251.71 USD
9/29/20251.71 USD
9/26/20251.66 USD
9/25/20251.71 USD
9/24/20251.76 USD
9/23/20251.68 USD
9/22/20251.76 USD
9/19/20251.79 USD
9/18/20251.79 USD
9/17/20251.77 USD
9/16/20251.78 USD
9/15/20251.78 USD
9/12/20252.49 USD
9/11/20252.61 USD
9/10/20253.16 USD
9/9/20252.81 USD
9/8/20252.74 USD
9/5/20252.56 USD
9/4/20252.34 USD
9/3/20252.49 USD
9/2/20252.63 USD
8/29/20252.42 USD
8/28/20252.47 USD
8/27/20252.51 USD
8/26/20252.56 USD
8/25/20252.63 USD
8/22/20252.57 USD
8/21/20252.65 USD
8/20/20252.19 USD
8/19/20252.10 USD
8/18/20252.02 USD
8/15/20251.95 USD
8/14/20252.06 USD
8/13/20252.08 USD
8/12/20251.98 USD
Access this data via the Eulerpool API
Get Free API Key

Bionano Genomics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
31.00 M USD
-227.31 M USD
-232.49 M USD
Jan 1, 2024
26.85 M USD
-110.16 M USD
-112.02 M USD
Jan 1, 2025
28.21 M USD
-33.34 M USD
-26.40 M USD
Jan 1, 2026 (e)
32.14 M USD
-31.58 M USD
-23.52 M USD
Jan 1, 2027 (e)
43.30 M USD
-42.55 M USD
-9.87 M USD
Jan 1, 2028 (e)
54.80 M USD
-53.84 M USD
-5.29 M USD
Jan 1, 2029 (e)
66.51 M USD
-65.36 M USD
-2.44 M USD
Jan 1, 2030 (e)
80.69 M USD
-79.29 M USD
2.04 M USD

Bionano Genomics Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 12, 2026, 1:26 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20162017201820192020202120222023202420252026e2027e2028e2029e2030e
6.009.0012.0010.008.0017.0027.0036.0030.0028.0032.0043.0054.0066.0080.00
–50.0033.33-16.67-20.00112.5058.8233.33-16.67-6.6714.2934.3825.5822.2221.21
50.0033.3325.0030.0025.0017.6518.5225.0020.0021.4321.4321.4321.4321.4321.43
3.003.003.003.002.003.005.009.006.006.006.869.2111.5714.1417.14
-21.00-22.00-20.00-27.00-38.00-77.00-131.00-227.00-110.00-33.00-31.00-42.00-53.00-65.00-79.00
-350.00-244.44-166.67-270.00-475.00-452.94-485.19-630.56-366.67-117.86-96.88-97.67-98.15-98.48-98.75
-18.00-23.00-18.00-29.00-41.00-72.00-132.00-232.00-112.00-26.00-23.00-9.00-5.00-2.002.00
–27.78-21.7461.1141.3875.6183.3375.76-51.72-76.79-11.54-60.87-44.44-60.00-200.00
5.455.23––10.430.480.500.681.905.455.455.455.455.455.45
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Bionano Genomics generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bionano Genomics retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bionano Genomics's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Bionano Genomics has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bionano Genomics's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Bionano Genomics stock margins

The Bionano Genomics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bionano Genomics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bionano Genomics.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
22.72 %
-454.21 %
-424.74 %
Jan 1, 2022
21.62 %
-478.83 %
-482.10 %
Jan 1, 2023
30.86 %
-733.34 %
-750.05 %
Jan 1, 2024
1.42 %
-410.28 %
-417.20 %
Jan 1, 2025
22.18 %
-118.18 %
-93.57 %
Jan 1, 2026 (e)
22.18 %
-98.26 %
-73.17 %
Jan 1, 2027 (e)
22.18 %
-98.26 %
-22.81 %
Jan 1, 2028 (e)
22.18 %
-98.26 %
-9.66 %

Bionano Genomics Stock Revenue, EBIT, Earnings per Share

The Bionano Genomics earnings per share therefore indicates how much revenue Bionano Genomics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
35.33 USD
-160.47 USD
-150.06 USD
Jan 1, 2022
54.48 USD
-260.89 USD
-262.67 USD
Jan 1, 2023
45.74 USD
-335.42 USD
-343.06 USD
Jan 1, 2024
14.11 USD
-57.90 USD
-58.87 USD
Jan 1, 2025
5.18 USD
-6.12 USD
-4.85 USD
Jan 1, 2026 (e)
3.16 USD
-5.80 USD
-2.31 USD
Jan 1, 2027 (e)
4.25 USD
-7.81 USD
-0.97 USD
Jan 1, 2028 (e)
5.38 USD
-9.89 USD
-0.52 USD

Bionano Genomics business model & stock analysis

Bionano Genomics Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Bionano Genomics Employees
Details
Date
Bionano Genomics Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Bionano Genomics Segments

Bionano Genomics Revenue by Segment (1/3)

  • Max

Product revenue
Product
Service and other revenue
Product and Service, Other
Details
Date
Product revenue
Product
Service and other revenue
Instruments
Consumables
Product and Service, Other
Other revenue
Jan 1, 2024
27.01 M USD
0.00 USD
3.77 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
26.74 M USD
0.00 USD
0.00 USD
0.00 USD
1.77 M USD
0.00 USD

Bionano Genomics Revenue by Segment (2/3)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Product revenue
Service and other revenue
Jan 1, 2024
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD

Bionano Genomics Revenue by Segment (3/3)

  • Max

Reportable Segment
Details
Date
Reportable Segment
Jan 1, 2024
30.78 M USD
Jan 1, 2025
28.51 M USD

Bionano Genomics Revenue by Region

  • 3 Years

  • 5 Years

  • Max

EMEA
Americas
North America
EMEIA
Asia Pacific
Details
Date
EMEA
Americas
North America
EMEIA
Asia Pacific
Jan 1, 2018
0.00 USD
0.00 USD
4.59 M USD
3.95 M USD
3.45 M USD
Jan 1, 2019
0.00 USD
0.00 USD
5.03 M USD
3.63 M USD
1.47 M USD
Jan 1, 2020
0.00 USD
0.00 USD
4.49 M USD
3.16 M USD
850,931.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
9.33 M USD
5.60 M USD
3.05 M USD
Jan 1, 2022
8.96 M USD
13.86 M USD
0.00 USD
0.00 USD
4.98 M USD
Jan 1, 2023
12.96 M USD
18.02 M USD
0.00 USD
0.00 USD
5.13 M USD
Jan 1, 2024
14.23 M USD
13.65 M USD
0.00 USD
0.00 USD
2.89 M USD
Jan 1, 2025
14.11 M USD
12.18 M USD
0.00 USD
0.00 USD
2.22 M USD

Bionano Genomics Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Bionano Genomics historical P/E ratio, EBIT multiple, and P/S ratio

Bionano Genomics annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Bionano Genomics shares outstanding

The number of shares of Bionano Genomics was 5.45 M in 2025. This indicates how many shares Bionano Genomics is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
482,700.00 Stocks
Jan 1, 2022
504,800.00 Stocks
Jan 1, 2023
677,700.00 Stocks
Jan 1, 2024
1.90 M Stocks
Jan 1, 2025
5.45 M Stocks
Jan 1, 2026 (e)
5.45 M Stocks
Jan 1, 2027 (e)
5.45 M Stocks
Jan 1, 2028 (e)
5.45 M Stocks

Bionano Genomics stock splits

In Bionano Genomics's history, there have been no stock splits.

Current Bionano Genomics forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
77.78 % (7)
Hold
22.22 % (2)
Sell
0.00 % (0)
12M Price Target
7.65
Last Price
1.16
Currency
USD
12M Return Potential
559.48 %
LTM Return
0 %

Bionano Genomics Analyst Rating Actions

DateFirmActionRatingReliability
4/13/2026
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
11/24/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
8/18/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
5/20/2025
Maxim Group
Maxim Group
UpgradeHoldBuy–
4/2/2025
Scotiabank
Scotiabank
MaintainedSector Perform75
11/15/2024
Ladenburg Thalmann
Ladenburg Thalmann
DowngradeBuyNeutral–
5/16/2024
BTIG
BTIG
MaintainedBuy–
3/7/2024
Scotiabank
Scotiabank
MaintainedSector Outperform75
11/13/2023
Maxim Group
Maxim Group
DowngradeBuyHold–
8/10/2023
BTIG
BTIG
MaintainedBuy–

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Bionano Genomics Earnings Calls

2025

Bionano Genomics Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/12/2026-0.70USD-7.63 MUSD-2026 Q2
5/13/2026-0.97USD-6.70 MUSD-2026 Q1
3/30/2026-1.43USD-8.01 MUSD-2025 Q4
11/13/2025-1.95USD-7.01 MUSD-2025 Q3
8/14/2025-2.46USD-7.14 MUSD-2025 Q2
11/6/2024-0.39USD-9.12 MUSD-2024 Q3
5/7/2024-0.77USD-11.07 MUSD-2024 Q1
3/7/2024-0.89USD-10.75 MUSD-2023 Q4
8/2/2023-0.11USD-10.57 MUSD-2023 Q2
5/3/2023-0.10USD-9.05 MUSD-2023 Q1

EESG©

Eulerpool ESG Scorecard© for the Bionano Genomics stock

23/100
4
Environment
19
Social
44
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Bionano Genomics shareholder structure

% Name
5.15717%
Lincoln Alternative Strategies LLC
Lincoln Alternative Strategies LLC
4.72457%
The Lind Partners, LLC
The Lind Partners, LLC
4.66601%
Heights Capital Management, Inc.
Heights Capital Management, Inc.
3.61002%
Iroquois Capital Management, LLC
Iroquois Capital Management, LLC
1.54715%
Abbe (Richard)
Abbe (Richard)
0.39367%
GSA Capital Partners LLP
GSA Capital Partners LLP

Bionano Genomics Beneficial Ownership Filings (SEC 13D/G)

Free Float
94.0%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
15.13%
WEALTH STRATEGY HOLDING LIMITED
WEALTH STRATEGY HOLDING LIMITED
SEC ↗
9.99%
Ayrton Capital LLC
Ayrton Capital LLC
SEC ↗
9.90%
CVI Investments, Inc.
CVI Investments, Inc.
SEC ↗
9.35%
Lind Global Fund III LP
Lind Global Fund III LP
SEC ↗
6.50%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
6.10%
27-4413262
27-4413262
SEC ↗
5.42%
Lincoln Alternative Strategies LLC
Lincoln Alternative Strategies LLC
SEC ↗
5.13%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
4.99%
Mitchell P. Kopin
Mitchell P. Kopin
SEC ↗
4.57%
Sio Capital Management, LLC   20-4586565
Sio Capital Management, LLC   20-4586565
SEC ↗

Bionano Genomics Executives and Management Board

13 members · avg. age 59 · 31 % women

RH

Dr. R. Erik Holmlin (57)

President, Chief Executive Officer, Principal Financial Officer, Director · since 2011

989,677.00 USD

Management

MO

Mr. Mark Oldakowski (51)

Chief Operating Officer

663,370.00 USD
AC

Dr. Alka Chaubey (52)

Chief Medical Officer

661,908.00 USD
MA

Mr. Mark Adamchak (45)

Vice President - Accounting, Principal Accounting Officer

–
JD

Mr. Jonathan Dixon (50)

General Counsel, Secretary

–
DH

Mr. David Holmes

Investor Relations Officer · since 2022

–

Board of Directors

DB

Dr. David Barker (83)

Independent Director

91,092.00 USD
AL

Dr. Albert Luderer (76)

Independent Chairman of the Board

87,622.00 USD
CT

Mr. Christopher Twomey (65)

Independent Director

76,857.00 USD
KV

Dr. Kristiina Vuori (57)

Independent Director

74,357.00 USD
HM

Ms. Hannah Mamuszka (48)

Independent Director

64,357.00 USD
YL

Dr. Yvonne Linney (63)

Independent Director

61,857.00 USD

Bionano Genomics Supply Chain

Bionano Genomics Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
8 companies
#NameTrend
1
AS ONE
Customer·Health Care Providers & Services·JP
0.49
0.69
0.86
0.52
0.43
0.39
2
Medicover B
Customer·SE
-0.05
0.28
0.69
0.76
0.28
0.36
3
OPKO Health
Customer·Health Care Providers & Services·US
0.66
0.43
0.88
0.80
0.41
0.32
#NameTrend
1
Berry Genomics A
Customer·Biotechnology·CN
-0.30
-0.72
0.62
0.80
0.90
-0.31
2
Quest Diagnostics
Customer·Health Care Providers & Services·US
0.51
0.27
0.31
0.82
0.10
0.12
3
PerkinElmer
Customer·Life Sciences Tools & Services·US
0.51
0.78
0.81
0.80
0.06
0.16
4
AddLife B
Customer·SE
0.23
0.57
0.72
0.81
0.47
0.24
5
Corteva
Customer·Chemicals·US
0.22
0.60
0.25
-0.56
-0.79
0.29

Frequently asked questions about Bionano Genomics

Analysts currently set an average price target of 7.65 USD for the Bionano Genomics stock (median: 7.65 USD), implying +559.5 % versus the latest price. The consensus is based on 9 analyst ratings.

Bionano Genomics Analyst Price Targets 2026

9 analysts currently rate the Bionano Genomics stock: 7 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Bionano Genomics to generate revenue of 32.14 M USD and earnings per share of -4.32 USD.

Bionano Genomics Analyst Price Targets 2026

Converted at the current exchange rate, the Bionano Genomics share trades at 1.01 EUR (1.16 USD).

The Bionano Genomics share (BNGO) is listed on 5 stock exchanges, including: NASDAQ (BNGO), Frankfurt (2Y3.F), München (2Y3.MU), Düsseldorf (2Y3.DU), London (0A4K.L).

No history available for Bionano Genomics.

The expected revenue of Bionano Genomics is 32.14 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Bionano Genomics is -23.52 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Bionano Genomics is currently -0.27. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bionano Genomics stock.

The price-to-sales ratio (P/S) of Bionano Genomics is currently 0.20. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bionano Genomics stock.

The Eulerpool Quality Score for Bionano Genomics is 2/10.

The ISIN of Bionano Genomics is US09075F4046. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Bionano Genomics is A2JRLZ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Bionano Genomics is BNGO. The ticker symbol is used to trade Bionano Genomics shares on the stock exchange.

Bionano Genomics paid dividends every year for the past 0 years.

Bionano Genomics is assigned to the 'Health' sector.

The dividends of Bionano Genomics are distributed in USD.

All fundamentals and in-depth analysis of Bionano Genomics

Our stock analysis for Bionano Genomics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bionano Genomics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Bionano Genomics Stock
Bionano Genomics Revenue→
Bionano Genomics Stock
Bionano Genomics Net Income→
Bionano Genomics Stock
Bionano Genomics P/E→
Bionano Genomics Stock
Bionano Genomics P/S→
Bionano Genomics Stock
Bionano Genomics EBIT→
Bionano Genomics Stock
Bionano Genomics Dividend→
Bionano Genomics Stock
Bionano Genomics Directors Dealings→
Bionano Genomics Stock
Bionano Genomics Stocks→
Bionano Genomics Stock
Bionano Genomics Market capitalization→
Bionano Genomics Stock
Bionano Genomics Debt→
Bionano Genomics Stock
Bionano Genomics Liabilities→
Bionano Genomics Stock
Bionano Genomics Equity→
Bionano Genomics Stock
Bionano Genomics AAQS→
Bionano Genomics Stock
Bionano Genomics Employees→
Bionano Genomics Stock
Bionano Genomics ROE→
Bionano Genomics Stock
Bionano Genomics ROA→
Bionano Genomics Stock
Bionano Genomics ROCE→
Bionano Genomics Stock
Bionano Genomics News→
Bionano Genomics Stock
Bionano Genomics Analyst Price Targets→

Health Stocks

BioneerBiomxBionetBiommBionik LaboratoriesBiomerieuxBionimeBiomericaBioNoteBiomea FusionBionovate TechnologiesBioMaximaAll Stocks A–Z →